Products and services

FILE - In this April 17, 2018 file photo, a woman rides a motorized scooter in Washington Square Park in San Francisco. Tired of San Francisco sidewalks being used as a testing ground for delivery robots, drones, and electric scooters, city supervisors will vote Tuesday, Dec. 10, 2019, to set up a new regulatory office that would require businesses to get permits before trying out new technology that uses public space. (AP Photo/Jeff Chiu, File)
December 10, 2019 - 6:51 pm
SAN FRANCISCO (AP) — Tired of San Francisco streets being used as a testing ground for the latest delivery technology and transportation apps, city leaders are now requiring businesses to get permits before trying out new high-tech ideas in public. Supporters of the legislation, which the Board of...
Read More
December 10, 2019 - 6:46 am
LONDON (AP) — Food delivery company Just Eat rejected a sweetened takeover bid from investment firm Prosus on Tuesday, saying that the 5 billion pound ($6.6 billion) offer still “significantly undervalues” the company. Prosus N.V., which is owned by the wealthy South African investment group...
Read More
In this April 16, 2019, photo, attendees take a close look at cars from BYD at the Auto Shanghai 2019 show in Shanghai. China's electric car sales are stalling following the end of multibillion-dollar subsidies that made it the biggest market for the technology. Communist leaders want to make China a leader in electric cars but are shifting the burden to the industry by imposing mandatory sales quotas (AP Photo/Ng Han Guan)
December 10, 2019 - 6:05 am
BEIJING (AP) — Looking for a new car, Yang Zhibo considered an electric but balked at prices that are thousands of dollars higher after Beijing wound down multibillion-dollar subsidies that made China the biggest market for the technology. The 27-year-old employee of a beverage distributor picked a...
Read More
People watch a TV screen showing a file image of a ground test of North Korea's rocket engine during a news program at the Seoul Railway Station in Seoul, South Korea, Monday, Dec. 9, 2019. North Korea said Sunday it carried out a "very important test" at its long-range rocket launch site that it reportedly rebuilt after having partially dismantled it after entering denuclearization talks with the United States last year. The sign reads: "Very important test." (AP Photo/Ahn Young-joon)
December 09, 2019 - 4:22 am
SEOUL, South Korea (AP) — A day after North Korea said it had performed a “very important test” at its long-range rocket launch site, there is wide speculation that it involved a new engine for either a space launch vehicle or a long-range missile. Whatever it was, the North Korean announcement...
Read More
In this Dec. 7, 2019, photo provided by the North Korean government, North Korean leader Kim Jong Un, center, cuts the ribbon during a ceremonial opening of the Yangdok Hot Spring Cultural Recreation Center in South Pyongan Province, North Korea. Independent journalists were not given access to cover the event depicted in this image distributed by the North Korean government. The content of this image is as provided and cannot be independently verified. Korean language watermark on image as provided by source reads: "KCNA" which is the abbreviation for Korean Central News Agency. (Korean Central News Agency/Korea News Service via AP)
December 09, 2019 - 3:06 am
SEOUL, South Korea (AP) — North Korean leader Kim Jong Un opened a new mountain spa and ski resort that's intended for people to enjoy “high civilization under socialism” in another example of the country using tourism exemptions in sanctions to build revenue for its broken economy. Kim cut the...
Read More
Senate Minority Leader Chuck Schumer of N.Y., points to a question as he speaks with reporters Tuesday, Dec. 3, 2019 in Washington, on Capitol Hill. (AP Photo/Alex Brandon)
December 08, 2019 - 6:09 pm
NEW YORK (AP) — The Senate’s top Democrat said Sunday that congressional leaders have reached a “real breakthrough” deal to give 12 weeks of paid parental leave to millions of federal workers as part of the annual defense policy bill. Sen. Charles Schumer said the agreement over the National...
Read More
December 08, 2019 - 11:52 am
NEW YORK (AP) — In November, newspaper publisher GateHouse completed its acquisition of USA Today owner Gannett, creating the largest newspaper publisher in the U.S. Executives behind the merger, which was funded in part by a high-interest, $1.8 billion loan from a private equity firm, have pledged...
Read More
Charles Flagg, who is stricken with Alzheimer's disease, sits for an infusion while participating in a study on the drug Aducanumab at Butler Hospital in Providence, R.I. New results were released on the experimental medicine whose maker claims it can slow the decline of Alzheimer's disease, the most common form of dementia. (AP Photo/Charles Krupa)
December 05, 2019 - 3:43 pm
SAN DIEGO (AP) — A company that claims to have the first drug to slow mental decline from Alzheimer's disease made its case to scientists Thursday but left them sharply divided over whether there’s enough evidence of effectiveness for the medicine to warrant federal approval. Excitement and...
Read More
December 05, 2019 - 10:28 am
NEW YORK (AP) — Stocks wobbled between small gains and losses on Wall Street in early trading Thursday as investors waited for the latest news on negotiations to end the trade war between the U.S. and China. The losses follow Wednesday’s advance on a report that Washington and Beijing could be on...
Read More
This undated photo provided by Acadia Pharmaceuticals Inc. shows a bottle of Nuplazid, a drug that was tested for treating psychosis related to dementia. If regulators agree, the drug could become the first treatment specifically for dementia-related psychosis and the first new medicine for Alzheimer's in nearly two decades. Results from a study on the drug were disclosed Wednesday, Dec. 4, 2019, at an Alzheimer's conference in San Diego. (Acadia Pharmaceuticals Inc. via AP)
December 04, 2019 - 8:53 pm
SAN DIEGO (AP) — A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's disease and other forms of dementia in a study that was stopped early because the benefit seemed clear. If regulators agree, the drug could become the first treatment specifically for...
Read More

Pages